These studies suggest promising paths to inhibit pathogenic TFH cells and IgE production in asthma, and also shed light on the development of novel immunotherapies in asthma patients by promoting Treg/TFR cell-mediated suppression of TFH cells. Here, IGHE is linked to asthma.